ClinicalTrials.gg
RecruitingNCT07624136Updated Jun 3, 2026

Effects of Kinesio Taping on Thoracolumbar Fascia Flexibility in Patients With Shoulder Injury

An interventional study of kinesio taping in Subacromial Impingement Syndrome and Shoulder Pain, sponsored by Kübra Sarıoğlu. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by Kübra Sarıoğlu · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 70 studies in Shoulder Impingement Syndrome with a site in Turkey — 12 open to participants now, 14 under way, none of them phase 3. Shoulder Impingement Syndrome · Turkey.

Planned enrollment
56th of 56
6 · median 48
Started
2026
with 5 others
No phase
55 of 70
8 open now
Primary completion
2026-09
later than 9 of 13 live
Registered
67th of 70
by date

Among the 70 studies in Shoulder Impingement Syndrome with a site in Turkey, this one is the 56th largest by planned enrollment of the 56 interventional ones that give a count, is one of 6 that started in 2026, is one of 55 with no phase, reaches primary completion later than 9 of the 13 other live ones, and was the 67th registered.

Shoulder Impingement Syndrome

321 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.

Browse Shoulder Impingement Syndrome studies →

Open to participants now

12 of the 70 studies in Shoulder Impingement Syndrome with a site in Turkey are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 32 Shoulder Impingement Syndrome studies recruiting now, 3 (9%) set no upper age limit and 25 (78%) stop at 75 or younger; 1 takes children under 18; 6 take healthy volunteers.

This study: 20 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Shoulder Impingement Syndrome with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this randomized controlled trial is to investigate the acute effects of fascia correction Kinesio Taping applied to the thoracolumbar fascia (TLF) in individuals with Subacromial Impingement Syndrome (SIS). Participants will be randomly allocated into an intervention group and a sham taping control group. The intervention group will receive fascia correction Kinesio Taping applied to the thoracolumbar region, while the control group will receive sham taping without therapeutic effect. Clinical parameters including pain intensity, trunk range of motion, thoracolumbar fascia flexibility, lumbar mobility, and posterior shoulder capsule tightness will be assessed before the intervention and 45 minutes after the application. This study aims to provide evidence regarding the acute clinical effects of thoracolumbar fascia modulation in individuals with Subacromial Impingement Syndrome.

Read the detailed description

Subacromial Impingement Syndrome (SIS) is one of the most common causes of shoulder pain and is characterized by pain, movement limitation, and functional impairment. Contemporary biomechanical perspectives suggest that shoulder function is influenced not only by local anatomical structures but also by proximal structures such as the thorax, spine, and thoracolumbar fascia. The thoracolumbar fascia plays an important role in force transmission between the upper and lower extremities and contributes to postural control and movement coordination. Therefore, interventions targeting the thoracolumbar fascia may influence shoulder function and related clinical outcomes.

This randomized controlled trial will include a total of 60 participants diagnosed with Subacromial Impingement Syndrome. Participants will be randomly assigned into two groups: an intervention group receiving fascia correction Kinesio Taping using the Ram's Head technique applied to the thoracolumbar fascia, and a control group receiving sham Kinesio Taping without therapeutic fascia correction.

In the intervention group, Y-shaped Kinesio Tape will be applied to the thoracolumbar region using the fascia correction technique. Low-to-moderate tape tension (10-50%) combined with manual oscillatory movements will be used to facilitate fascial mobilization and modulate tissue glide capacity. The sham group will receive taping without therapeutic fascial correction.

Assessments will be performed immediately before the intervention and 45 minutes after tape application. Outcome measures will include pain intensity during rest and activity assessed using the Visual Analog Scale (VAS), trunk range of motion measured by goniometry, trunk flexibility assessed by tape measurements, thoracolumbar fascia flexibility evaluated using a goniometric platform, lumbar mobility assessed by the Modified Schober Test, and posterior shoulder capsule tightness measurement.

The primary aim of this study is to investigate the acute clinical effects of fascia correction Kinesio Taping applied to the thoracolumbar fascia in individuals with Subacromial Impingement Syndrome and to provide evidence regarding the potential effects of fascial modulation on pain, mobility, range of motion, and tissue flexibility.

03

Conditions studied

  • Subacromial Impingement Syndrome
  • Shoulder Pain

Keywords

  • shoulder pain
  • fascial chain
  • sobacromial impingment syndrome
04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age between 20 and 40 years,
  • (BMI) within the normal range (20-24.9 kg/m²),
  • a chronic (symptoms persisting for >3 months) SIS diagnosis

Exclusion criteria

Exclusion Criteria:

  • any shoulder pathology other than SIS (e.g., rotator cuff tear, glenohumeral joint problems),
  • inability to perform 90° shoulder flexion due to joint limitation or pain ≥8 on the VAS,
  • overweight or obesity ( >25 kg/m²),
  • previous back surgery,
  • low back pain within the last six months, scoliosis, radiologically diagnosed kyphosis or thoracolumbar disc herniation, sacroiliac joint problems, restricted pelvic range of motion (anterior-posterior pelvic tilt), and scapular dyskinesia.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
6 participants (estimated)

Study arms

  • Active comparator
    Kinesio Taping Group

    Participants in this group will receive the "Ram's Horn" fascia correction technique using Kinesio Taping applied to the thoracolumbar fascia region. The base (anchor) of a Y-shaped kinesiology tape will be applied without tension between the lateral iliac crest and the axillary line. From this anchor point, the tape will be divided into two tails. The first tail will be directed superiorly over the scapular region and attached along the superior border of the scapula. The second tail will be directed inferiorly and posteriorly across the lumbar region toward the superior aspect of the iliac crest, creating a configuration resembling a ram's horn. During the application of both tape tails, oscillatory fascial correction movements will be performed manually by shifting the underlying fascia while the tape is applied. No tension will be applied to the anchor portion of the tape. The technique is intended to provide a fascial correction effect throughout the thoracolumbar region.

    Other: kinesio taping

  • Sham comparator
    control group

    Participants in the sham group will receive a placebo taping application using a Y-shaped kinesiology tape. The tape will be applied without tension and without the oscillatory fascial correction maneuvers used in the Ram's Horn technique. The anchor will be placed near the axillary region, and both tails of the Y-shaped tape will be directed inferiorly toward the iliac crest in a random, non-corrective configuration. The tape will not be arranged in the characteristic ram's horn pattern and will be applied without any intended therapeutic fascial correction effect.

    Other: kinesio taping

Interventions

  • Otherkinesio taping

    Assessments will be performed immediately before the intervention and 45 minutes after tape application in both groups. Outcome measures will include pain intensity during rest and activity assessed using the Visual Analog Scale (VAS), trunk range of motion measured by goniometry, trunk flexibility assessed by tape measurements, thoracolumbar fascia flexibility evaluated using a goniometric platform, lumbar mobility assessed by the Modified Schober Test, and posterior shoulder capsule tightness. Participants in the intervention group will receive corrective kinesio taping applied in a horn-shaped configuration, whereas the sham group will receive a tension-free tape application from the lateral trunk/axillary region toward the hip without therapeutic fascial correction.

    Also known as: 1.Therapeutic Kinesio Taping Group, 2.Sham Kinesio Taping Group

06

What researchers measure

Primary outcomes

  1. thoracolumbar fascia flexibility

    The flexibility of the thoracolumbar fascia was evaluated using a goniometric platform. A goniometric platform was placed on a table in front of the participants. Patients were asked to clasp their hands in front at 90° of shoulder flexion, holding a wooden marker between their hands. Patients performed maximum trunk rotation, first to the right and then to the left, while ensuring their arms followed the movement of the trunk. The rotation degree reached by the marker was recorded on the goniometric platform. The test was repeated three times for each direction with one-minute rest intervals, and the average values were recorded. A decrease in rotation range during repeated trials or restricted movement was considered indicative of TLF tightness.

    Time frame: 15 minutes

Secondary outcomes

  1. pain assessment, rest and active

    Pain intensity was evaluated using a 10 cm VAS (0: no pain, 10: worst pain). Measurements were recorded at baseline and 45 minutes post-taping in two conditions: Resting Pain: Pain level while the participant was in a relaxed position. Activity Pain: Pain level during basic activities, such as arm movements and walking. The distance between the marked point and the zero point was measured in centimeters using a ruler

    Time frame: 3 minutes

  2. Modified schober test

    The physiotherapist determined the SIPS with a pencil. The midpoint of the line connecting the Spina İliaca Posterior Superior (SIPS) is marked. The point 10 cm above and 5 cm below this point was determined with a tape measure. The person was asked to perform maximum trunk flexion. The distance between these two points was measured. The difference was less than 5 cm, indicating low back flexibility

    Time frame: 5 minutes

Other outcomes

  1. Shoulder posterior capsule shortness:

    Shoulder posterior capsule shortness was measured and evaluated with a tape measure. Participants were positioned in a side-lying position at the edge of the examination table. The scapula of the measured side was stabilized by the physiotherapist. The shoulder was moved into horizontal adduction and the arm was allowed to drop toward the table. The distance between the olecranon and the table surface was measured and recorded in centimeters

    Time frame: 5 minutes

  2. Trunk Range of Motion:

    The ROM values were evaluated using a goniometer. The results were recorded in degrees (°) for lateral flexion, flexion and extension directions

    Time frame: 5 minutes

  3. Trunk flexibility

    both sides rotation, lateral flexion and extension

    Time frame: 5 minutes

07

Study locations

1 of 1 sites recruiting
  • Hacettepe Sporcu Sağlığı Ünitesi
    Ankara, Altindag 06100, Turkey (Türkiye)
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Sep 2026, 4 months after the start.

Of 171 non-industry interventional studies with no phase under Shoulder Impingement Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 4 months is below that.

Counting every sponsor, half of 173 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2026
First posted
Jun 3, 2026
StartActual
May 20, 2026
Primary completionEst.
Sep 20, 2026
CompletionEst.
Sep 20, 2026
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07624136
Lead sponsor
Kübra Sarıoğlu
Responsible party
Kübra Sarıoğlu (PhD graduated, Hacettepe University) — Sponsor-investigator
First posted
Jun 3, 2026
Start date
May 20, 2026
Primary completion
Sep 20, 2026 (estimated)
Completion
Sep 20, 2026 (estimated)
Last update
Jun 3, 2026

Study contacts

GÜL BALTACI, Prof. Dr.
Contact
ygulbaltaci@gmail.com
+905323963279
KÜBRA SARIOĞLU, PhD
Contact
fztkubrasarioglu@gmail.com
+905369370561
KÜBRA SARIOĞLU, PhD
principal investigator · HACETTEPE ÜNİVERSİTESİ ,Anafartalar, Talatpaşa Blv No:47, 06100 Altındağ/Ankara
Gül Baltacı, Prof.Dr.
study director · Atlas University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion